Literature DB >> 24583837

ALK-positive inflammatory myofibroblastic tumor of the abdomen with widespread microscopic multifocality.

Luisa Lorenzi1, Marta Cigognetti1, Daniela Medicina1, Vilma Pellegrini1, Piera Balzarini1, Renzo Cestari2, Fabio Facchetti3.   

Abstract

Inflammatory myofibroblastic tumor (IMT) is a locally aggressive neoplasm, most frequently occurring in the abdominal cavity as multiple recurrent nodules. We report a case of IMT in a 24-year-old male presenting as multiple nodules involving the omentum, the liver, and the colon. Spindle tumor cells expressed ALK with a cytoplasmic granular distribution, the CLTC-ALK fusion gene was demonstrated by reverse-transcriptase polymerase chain reaction analysis, and break-apart fluorescence in situ hybridization (FISH) probes for the ALK gene showed a pathological pattern (single red signal associated with 1/2 normal fused signals) highly suggestive for combined gene fusion and deletion. To reduce the surgically unresectable liver mass, the patient was treated with crizotinib, and after 4 months of treatment the disease was defined stable according to RECIST criteria. Interestingly, ALK and FISH/FICTION analysis revealed that tumor cells were widely dispersed as multiple microscopic foci or as single cells beneath the omental mesothelium. These findings indicate that IMT multifocality might result either from dissemination from the main tumor mass or development of multiple independent neoplastic foci; furthermore, they underline the need of omentectomy in abdominal IMT to obtain surgical radicality.
© The Author(s) 2014.

Entities:  

Keywords:  ALK; inflammatory myofibroblastic tumor; microscopic multifocality; omentum

Mesh:

Substances:

Year:  2014        PMID: 24583837     DOI: 10.1177/1066896914525232

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  4 in total

1.  Multiple malignant inflammatory myofibroblastic tumors of the jejunum: A case report and literature review.

Authors:  Audrius Dulskas; Aurimas Klivickas; Alfredas Kilius; Narimantas E Samalavicius; Romualdas Sumauskas; Rytis Markelis
Journal:  Oncol Lett       Date:  2015-12-24       Impact factor: 2.967

2.  Molecular Tumor Board Guides Successful Treatment of a Rare, Locally Aggressive, Uterine Mesenchymal Neoplasm.

Authors:  Elaine M Walsh; Deyin Xing; Melissa H Lippitt; Amanda N Fader; Stephanie L Wethington; Christian F Meyer; Stephanie L Gaillard
Journal:  JCO Precis Oncol       Date:  2021-02-05

3.  STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.

Authors:  Vivek Subbiah; Caitlin McMahon; Shreyaskumar Patel; Ralph Zinner; Elvio G Silva; Julia A Elvin; Ishwaria M Subbiah; Chimela Ohaji; Dhakshina Moorthy Ganeshan; Deepa Anand; Charles F Levenback; Jenny Berry; Tim Brennan; Juliann Chmielecki; Zachary R Chalmers; John Mayfield; Vincent A Miller; Philip J Stephens; Jeffrey S Ross; Siraj M Ali
Journal:  J Hematol Oncol       Date:  2015-06-11       Impact factor: 17.388

4.  Locally Advanced Inflammatory Myofibroblastic Tumor Treated With Targeted Therapy: A Case Report and Literature Review.

Authors:  Charis Durham; Matthew Clemons; Alwin Alias; Kartik Konduri
Journal:  Cureus       Date:  2022-07-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.